SEC Filing Summary: Marex Group Ltd (Form 13F)
Business Context and Reporting Period
Company: Marex Group Ltd (Reporting Manager)
Filing Type: Form 13F Information Table
Reporting Period: Quarter ended March 31, 2025
Context: This filing discloses the equity securities held by Marex Group Ltd at the end of the reporting period. Marex Group is a global financial services firm specializing in derivatives trading and risk management. The portfolio reflects a diversified mix of equities, exchange-traded funds (ETFs), and leveraged products across technology, energy, healthcare, and financial sectors.
Key Financial Metrics and Portfolio Composition
Revenue, Profit, Cash Flow, Margins, Debt, Liquidity: The filing text does not provide Marex Group's internal financial performance metrics (revenue, profit, cash flow, margins, debt, or liquidity). Form 13F filings strictly report external equity holdings.
Portfolio Highlights (Selected Holdings by Value):
- Technology & Semiconductors: Significant exposure to NVIDIA Corporation ($206.5M), Microsoft Corporation ($67.6M), Broadcom Inc ($97.1M), and Super Micro Computer Inc ($29.5M).
- Cryptocurrency & Digital Assets: Heavy allocation to Bitcoin and Ethereum ETFs, including Coinbase Global Inc ($1.2M), MicroStrategy Inc ($480.9M), and various Bitcoin Trust ETFs totaling over $296M in value.
- Healthcare & Biotech: Major positions in Eli Lilly & Co ($159.0M), Novo-Nordisk A/S ($3.2M), and Moderna Inc ($1.7M).
- Energy & Materials: Holdings in Tesla Inc ($142.5M), Ford Motor Co ($849.5M), and various uranium and mining ETFs.
- Financials: Positions in JPMorgan Chase & Co ($6.5M), Goldman Sachs Group Inc ($29.8M), and Berkshire Hathaway Inc ($19.2M).
Material Changes and Voting Authority
Voting Authority: The filing indicates that Marex Group holds voting authority for the reported securities. The "Voting Authority" column distinguishes between Sole, Shared, and None, with the majority of holdings listed under "Sole" or "Shared" discretion.
Portfolio Turnover: The filing lists numerous positions with "DFND 3" (Discretionary) and "DFND 1" (Non-Discretionary) codes, suggesting a mix of managed accounts. Specific changes from the prior quarter cannot be calculated without the previous filing, but the presence of large positions in volatile sectors (e.g., Crypto, Semiconductors) indicates active management.
Guidance, Outlook, and Risks
Management Commentary: No management commentary, guidance, or outlook is provided in this filing. Form 13F is a regulatory disclosure of holdings, not a narrative report.
Risks and Contingencies:
- Concentration Risk: Significant exposure to high-volatility sectors, particularly cryptocurrency-related equities (MicroStrategy, Coinbase) and leveraged ETFs (e.g., 2X Long TSLA, 3X Long NVDA).
- Market Risk: The portfolio includes substantial positions in technology and energy stocks, which are subject to significant market fluctuations.
- Leverage: Holdings in leveraged ETFs (e.g., Direxion Daily S&P 500 Bull 3X) introduce amplified risk relative to the underlying index.
Important Facts for Investors to Verify
- Actual Performance: Verify Marex Group's actual financial results (revenue, net income) in their separate 10-K or 10-Q filings, as this document only shows asset holdings.
- Account Types: Confirm the proportion of "Discretionary" vs. "Non-Discretionary" accounts to understand how much of the portfolio is actively managed by Marex versus client-directed.
- Leveraged Exposure: Review the specific holdings in leveraged ETFs (e.g., GraniteShares 2X Long TSLA, Direxion 3X Bull) to assess the risk profile of the portfolio.
- Crypto Correlation: Note the heavy weighting in Bitcoin and Ethereum ETFs and related equities, which may indicate a strategic bet on digital asset adoption.
- Valuation Accuracy: The values reported are "to the nearest dollar" and represent the market value at the end of the quarter; current market prices may differ significantly.